论文部分内容阅读
目的:观察药物联合超短波治疗小儿支原体肺炎的临床疗效及安全性。方法:将支原体肺炎患儿64例,随机分为观察组34例,对照组30例,对照组采用阿奇霉素治疗,观察组在对照组的基础上超短波辅助治疗,比较2组患儿临床疗效。结果:2个疗程后观察组有效率为97.06%,对照组为83.33%,差异有统计学意义(P<0.01);咳嗽缓解时间观察组为(5.21±1.39)天,对照组为(6.53±1.57)天,差异有统计学意义(P<0.01)。结论:肺部超短波辅助治疗小儿支原体肺炎疗效确切,能缩短疗程。
Objective: To observe the clinical efficacy and safety of drug combined with ultrashort wave therapy in children with mycoplasma pneumonia. Methods: 64 cases of children with mycoplasma pneumonia were randomly divided into observation group 34 cases, control group 30 cases, the control group treated with azithromycin, the observation group in the control group based on ultrashort wave adjuvant therapy, the clinical efficacy of two groups were compared. Results: The effective rate of the observation group after two courses of treatment was 97.06% and that of the control group was 83.33%, the difference was statistically significant (P <0.01); the time of cough relief was (5.21 ± 1.39) days in the observation group and (6.53 ± 1.57) days, the difference was statistically significant (P <0.01). Conclusion: Pulmonary ultrashort wave assisted treatment of children with mycoplasma pneumonia exact effect, can shorten the course of treatment.